Loading...
Market
Story
Eli Lilly to Invest $1.8 Billion to Expand Drug Manufacturing in Ireland Facility
Sep 12, 2024, 09:32 AM
Eli Lilly, valued at $863.36 billion as of September 10, is making a significant investment to expand its manufacturing capabilities. The pharmaceutical giant announced a $1.8 billion investment to boost production of its blockbuster drugs for weight loss, diabetes, and Alzheimer's disease. This expansion includes a €927 million investment at its facility in Raheen, Limerick, Ireland, which will create 150 new jobs. The move underscores Lilly's commitment to addressing the growing demand for treatments in these critical areas.
View original story
Similar markets
Below 10% • 25%
10% to 15% • 25%
15% to 20% • 25%
Above 20% • 25%
Less than 5% • 25%
5% to 10% • 25%
10% to 15% • 25%
More than 15% • 25%
$45.4 billion to $46.6 billion • 25%
Less than $45.4 billion • 25%
More than $46.6 billion • 25%
Between $46.0 billion and $46.6 billion • 25%
Below $45 billion • 25%
$45 billion to $45.5 billion • 25%
$45.5 billion to $46 billion • 25%
Above $46 billion • 25%
Below $8 billion • 25%
$8 billion to $10 billion • 25%
$10 billion to $12 billion • 25%
Above $12 billion • 25%
Negative growth • 25%
0-5% growth • 25%
5-10% growth • 25%
Over 10% growth • 25%
Increase by more than 5% • 25%
Increase by 0-5% • 25%
Decrease by 0-5% • 25%
Decrease by more than 5% • 25%
Below $1.00 • 25%
$1.00 to $1.25 • 25%
$1.26 to $1.50 • 25%
Above $1.50 • 25%
Below $900 • 25%
$900 to $950 • 25%
$950 to $1000 • 25%
Above $1000 • 25%
Less than $500 • 25%
$500 to $600 • 25%
$600 to $700 • 25%
More than $700 • 25%
Less than $400 • 25%
$400 to $450 • 25%
$450 to $500 • 25%
More than $500 • 25%